Brunier G
J CANNT. 1990 Spring:15-7.
In the past, the focus of the treatment of the anemia of chronic renal failure was on improving methods of dialysis and minimizing blood loss, combined with the use of anabolic steroids, blood transfusions when necessary, and chelating agents. It is only recently that the underlying pathology for the anemia of chronic renal failure has been addressed. Now there is the potential to correct this anemia, in most cases completely, through replacement of the hormone erythropoietin by therapy with recombinant human erythropoietin.
过去,慢性肾衰竭贫血的治疗重点在于改进透析方法、减少失血,同时使用合成代谢类固醇、必要时输血以及螯合剂。直到最近,慢性肾衰竭贫血的潜在病理才得到关注。现在,通过用重组人促红细胞生成素进行治疗来替代促红细胞生成素激素,在大多数情况下有可能完全纠正这种贫血。